Boston Scientific Corporation
BSX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,846 | $1,592 | $698 | $1,041 |
| Dep. & Amort. | $1,269 | $1,196 | $1,136 | $1,093 |
| Deferred Tax | $0 | -$1 | -$63 | -$124 |
| Stock-Based Comp. | $266 | $233 | $220 | $194 |
| Change in WC | -$462 | -$770 | -$1,005 | -$351 |
| Other Non-Cash | $516 | $253 | $540 | $18 |
| Operating Cash Flow | $3,435 | $2,503 | $1,526 | $1,870 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$790 | -$711 | -$612 | -$554 |
| Net Acquisitions | -$4,640 | -$1,811 | -$1,537 | -$1,432 |
| Inv. Purchases | $0 | $0 | -$24 | $96 |
| Inv. Sales/Matur. | $0 | $0 | $56 | $294 |
| Other Inv. Act. | -$257 | -$52 | $106 | -$1 |
| Investing Cash Flow | -$5,687 | -$2,574 | -$2,011 | -$1,597 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,827 | -$4 | -$165 | $0 |
| Stock Issued | $230 | $182 | $0 | $110 |
| Stock Repurch. | $0 | $0 | $136 | $0 |
| Dividends Paid | $0 | -$28 | -$55 | -$55 |
| Other Fin. Act. | -$243 | -$145 | -$464 | -$150 |
| Financing Cash Flow | $1,814 | $5 | -$548 | -$95 |
| Forex Effect | -$11 | -$16 | -$9 | -$8 |
| Net Chg. in Cash | -$449 | -$82 | -$1,042 | $171 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,055 | $1,077 | $2,168 | $1,995 |
| End Cash | $606 | $995 | $1,126 | $2,168 |
| Free Cash Flow | $2,645 | $1,703 | $914 | $1,316 |